Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,320.43 +5,432.75 (+9.23%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Roche Holding AG (RHHVF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:29PM EDT
| Previous close | 235.30 |
| Open | 238.06 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 237.29 - 240.41 |
| 52-week range | 234.20 - 323.78 |
| Volume | |
| Avg. volume | 10,454 |
| Market cap | 192.543B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 15.20 |
| EPS (TTM) | 15.61 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 10.86 (4.58%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.